Please login to the form below

Not currently logged in
Email:
Password:

Horizon Discovery appoints executive director

David Smoller is chief business officer at the genomics firm
david-smoller horizon

UK-based genetic research company Horizon Discovery has named Dr David Smoller as an executive director of the board.

Smoller joined Horizon as chief business officer as part of the form's acquisition of Sage Labs for $48m in September this year.

Of his appointment, he said: “The integration of Sage Labs and Horizon is progressing well and I am delighted to be joining the Horizon board at this exciting time for the company.”

His previous roles include the position of CEO at Sage Labs, chief scientific officer of Sigma-Aldrich and president of its research biotechnology business unit.

He also served as president of ProteoPlex, a seed stage spinout focusing on proteomics, which was acquired by Merck KGaA in 2003, and founded Genomes Systems, acquired by Incyte Genomics in 1996.

Horizon is a UK-based biotech focused on genomics research and the development of personalised medicines. It has partnerships with several major pharma companies, including AstraZeneca.

The company has undergone expansion in recent years with other senior appointments including GSK and Abbott veteran Dr Ian Gilham as chairman and the addition of AstraZeneca's head of oncology R&D Susan Galbraith to Horizon's board.

4th November 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics